BioCryst Pharmaceuticals shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioCryst Pharmaceuticals by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $910k | 120k | 7.60 |
| 2024-06-30 | $740k | 120k | 6.18 |
| 2023-12-31 | $583k | 97k | 5.99 |
| 2023-09-30 | $689k | 97k | 7.08 |
| 2023-06-30 | $685k | 97k | 7.04 |
| 2023-03-31 | $812k | 97k | 8.34 |
| 2022-12-31 | $1.1M | 97k | 11.48 |
| 2022-09-30 | $1.2M | 97k | 12.60 |
| 2022-06-30 | $1.0M | 97k | 10.58 |
| 2022-03-31 | $1.6M | 97k | 16.26 |
| 2021-12-31 | $859k | 62k | 13.85 |
| 2021-09-30 | $891k | 62k | 14.37 |
| 2021-06-30 | $1.1M | 68k | 15.81 |
| 2021-03-31 | $693k | 68k | 10.17 |
| 2020-12-31 | $543k | 73k | 7.45 |
| 2020-09-30 | $241k | 70k | 3.44 |
| 2020-06-30 | $334k | 70k | 4.77 |
| 2020-03-31 | $78k | 39k | 2.00 |
| 2019-12-31 | $243k | 70k | 3.45 |
| 2019-09-30 | $145k | 51k | 2.87 |
| 2019-06-30 | $192k | 51k | 3.79 |
| 2019-03-31 | $412k | 51k | 8.14 |
| 2018-12-31 | $408k | 51k | 8.07 |
| 2018-09-30 | $604k | 79k | 7.63 |
| 2018-06-30 | $246k | 43k | 5.74 |
| 2018-03-31 | $205k | 43k | 4.78 |
| 2017-12-31 | $211k | 43k | 4.92 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors